Scott Juda, Director at Inmune Bio, Inc. (INMB), bought 2,500 shares at $13.55 ($34K) on 2021-11-17, disclosed to the SEC on 2021-11-17.
Open-market purchase of $34k INMB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| INMB | BUY | 2023-11-13 | $49K | — | Filing → |
| INMB | BUY | 2019-08-22 | $30K | — | Filing → |
| INMB | BUY | 2019-06-04 | $60K | — | Filing → |